| View |
|
DRP-11026-02
|
Acetylcysteine
|
None
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Synmosa Biopharma Corporation (Synmosa Plant)
|
Taiwan
|
CLIDP Conversion
|
21 February 2024
|
06 January 2027
|
| View |
|
DRP-11043-01
|
Acetylcysteine
|
Appcystein
|
100 mg/ 5mL
|
Syrup (Strawberry-Banana Flavor)
|
Mucolytic
|
LifeSquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
12 February 2024
|
18 January 2027
|
| View |
|
DRP-11044-06
|
Potassium Citrate
|
K-Citriz
|
1080 mg
|
Extended-Release Tablet
|
Antiurolithic
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
01 March 2024
|
18 January 2027
|
| View |
|
DRP-11048-01
|
Telmisartan
|
Merit
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker(ARB)
|
Intas Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
19 February 2024
|
19 January 2027
|
| View |
|
DRP-11057-06
|
Clopidogrel
|
Sabigrel
|
75 mg
|
Film-Coated Tablet
|
Platelet Aggregation Inhibitor
|
Centurion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 February 2024
|
20 January 2027
|
| View |
|
DRP-11057-07
|
Clopidogrel
|
Milogrel
|
75 mg
|
Film-Coated Tablet
|
Platelet Aggregation Inhibitor
|
Centurion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 March 2024
|
20 January 2027
|
| View |
|
DRP-11106-01
|
Co-Amoxiclav
|
Amixlo
|
312.5 mg/ 5 mL
|
Powder for Oral Suspension (see reverse for formulation)
|
Antibacterial (Penicillin/ Beta Lactamase Inhibitor)
|
Medopharm Private Limited
|
India
|
CLIDP Conversion
|
16 January 2024
|
03 February 2027
|
| View |
|
DRP-11244-01
|
Ceftriaxone (as sodium) + Sulbactam (as sodium)
|
Traxulev
|
1 g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin/Beta-lactamase Inhibitor)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
02 February 2024
|
18 February 2027
|
| View |
|
DRP-12991-01
|
Mupirocin
|
Kodabact
|
20mg/g (2% w/w)
|
Topical Ointment
|
Antibacterial
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
29 May 2023
|
14 November 2027
|
| View |
|
DRP-11353-01
|
Isoflurane
|
Iso-floe
|
100% v/v
|
Volatile Liquid for Inhalation
|
General Anesthetic (Halogenated Hydrocarbon)
|
Lunan Better Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
12 February 2024
|
03 March 2027
|
| View |
|
DRP-11401-05
|
Capecitabine
|
Capebin
|
500mg
|
Film-coated Tablet
|
Antineoplastic (Pyrimidine Analogue)
|
Laboratorio Eczane Pharma S.A.
|
Argentine Republic
|
CLIDP Conversion
|
19 February 2024
|
09 March 2027
|
| View |
|
DRP-11432-01
|
Loratadine
|
Lorakalm
|
10 mg
|
Tablet
|
Antihistamine
|
Kopran Limited
|
India
|
CLIDP Conversion
|
26 February 2024
|
14 March 2027
|
| View |
|
DRP-11435-01
|
Doxycycline (as hyclate)
|
Leptoxy
|
100 mg
|
Capsule
|
Antibacterial (Tetracycline)
|
Kopran Limited
|
India
|
CLIDP Conversion
|
02 February 2024
|
14 March 2027
|
| View |
|
DRP-11452-01
|
Montelukast (as sodium)
|
Gentakast 5
|
5 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Ratnatris Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 February 2024
|
14 March 2027
|
| View |
|
DRP-11488-01
|
Gliclazide
|
None
|
30 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
01 March 2024
|
17 March 2027
|
| View |
|
DRP-11552-02
|
Candesartan cilexetil
|
None
|
16 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
01 March 2024
|
29 May 2027
|
| View |
|
DRP-11588-01
|
Ofloxacin
|
Ofla-Drops
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution
|
Antibacterial (Fluoroquinolone)
|
Skymap Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 February 2024
|
30 March 2027
|
| View |
|
DRP-11588-02
|
Ofloxacin
|
Oflaz
|
3 mg / mL (0.3% w/v)
|
Ophthalmic Solution
|
Antibacterial (Fluoroquinolone)
|
Skymap Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 February 2024
|
30 March 2027
|
| View |
|
DRP-11636-02
|
Amlodipine (as besilate)
|
Gopres 10
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Ratnatris Pharmaceutical Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 February 2024
|
04 April 2027
|
| View |
|
DRP-11645-02
|
Paracetamol
|
Parabam
|
500 mg
|
Tablet
|
Analgesic/Antipyretic (Anilide)
|
Pharmatechnica Laboratory Inc.
|
|
CLIDP Conversion
|
06 February 2024
|
15 October 2027
|